Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.4120
-0.0022 (-0.53%)
May 21, 2025, 1:31 PM - Market open
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,968,602
Market Cap
9.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4 | 0 | - |
Dec 31, 2023 | 4 | 0 | - |
Dec 31, 2022 | 4 | 1 | 33.33% |
Dec 31, 2021 | 3 | 0 | - |
Dec 31, 2020 | 3 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ACXP News
- 7 days ago - Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update - PRNewsWire
- 21 days ago - Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update - PRNewsWire
- 23 days ago - Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase - PRNewsWire
- 4 weeks ago - Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - PRNewsWire
- 2 months ago - Acurx Pharmaceuticals, Inc. (ACXP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - PRNewsWire
- 2 months ago - Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering - PRNewsWire